Eterna Therapeutics announced the appointment of Jeff Karp, Ph.D. to Eterna’s Scientific Advisory Board. Karp is the Distinguished Chair in Clinical Anesthesiology, Perioperative and Pain Medicine at Brigham and Women’s Hospital and Professor of Anesthesia at Harvard Medical School in Boston.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on ERNA:
- Jeff Karp, Ph.D., Joins Eterna’s Scientific Advisory Board
- Eterna Therapeutics Reports Financial Results for Fourth Quarter and Full Year 2022 and Recent Business Highlights
- Eterna Therapeutics Enters Into Option and License Agreement with Lineage Cell Therapeutics to Develop Hypoimmune Pluripotent Cell Lines for Multiple Neurology Indications
- Eterna enters into option, license agreement with Lineage Cell Therapeutics
